Panel discussion with leading medical oncologists on the continuum of care in recurrent/metastatic head and neck cancer

As we continue to explore the continuum of care for the treatment of recurrent/metastatic squamous cell carcinoma of the head and neck, leading medical oncologists Professor Jan Vermorken, Dr Lisa Licitra and Dr Ana Castro discuss the role of the standard of care (EXTREME regimen including cetuximab) and emerging immunotherapy agents (including nivolumab).